Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic malignancies.

J I Tsao1, J DeSanctis, R L Rossi

  • 1Department of Surgery, Tufts University School of Medicine, Burlington, Massachusetts, USA.

The Surgical Clinics of North America
|June 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Northward Expansion of Amblyomma americanum (Acari: Ixodidae) into Southwestern Michigan.

Journal of medical entomology·2022
Same author

First Report of Phakopsora pachyrhizi, the Causal Organism of Soybean Rust in the Province of Misiones, Argentina.

Plant disease·2019
Same author

Acquisition of Borrelia burgdorferi Infection by Larval Ixodes scapularis (Acari: Ixodidae) Associated With Engorgement Measures.

Journal of medical entomology·2017
Same author

Reverse line blot probe design and polymerase chain reaction optimization for bloodmeal analysis of ticks from the eastern United States.

Journal of medical entomology·2012
Same author

Biodiversity and Lyme disease: dilution or amplification?

Epidemics·2011
Same author

High-prevalence Borrelia miyamotoi infection among [corrected] wild turkeys (Meleagris gallopavo) in Tennessee.

Journal of medical entomology·2010
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Despite advances in liver cancer treatment, recurrence remains a major challenge. Ongoing laboratory research into molecular and genetic factors offers hope for improved therapies and patient survival.

Area of Science:

  • Hepatobiliary Malignancies
  • Cancer Research
  • Molecular Oncology

Background:

  • Significant progress in liver cancer treatment over the last decade, including diagnostics, surgical resection, ablative therapies, and multimodal approaches.
  • Despite advancements, over 70% of treated patients experience recurrence, leading to mortality.
  • Liver cancer recurrence remains a critical unmet need in oncology.

Purpose of the Study:

  • To review current therapeutic strategies for liver malignancies.
  • To highlight the persistent challenge of tumor recurrence after treatment.
  • To emphasize the importance of ongoing laboratory research for future therapeutic development.

Main Methods:

  • Review of recent advancements in liver cancer diagnostics and treatment modalities.

Related Experiment Videos

  • Analysis of recurrence patterns and outcomes in treated patients.
  • Exploration of current laboratory investigations into cancer pathophysiology.

    • Main Results:

    • Current treatments have improved but have not eradicated the problem of liver cancer recurrence.
    • Laboratory research is actively investigating the molecular and genetic underpinnings of liver cancer.
    • Understanding cancer emergence and spread is key to developing novel therapies.

    Conclusions:

    • Liver cancer recurrence remains a significant cause of mortality despite therapeutic progress.
    • Further research into molecular and genetic mechanisms is crucial for advancing treatment.
    • Future therapies hold promise for improving disease-free survival in liver cancer patients.